Tom Rider
YOU?
Author Swipe
View article: A patient with widespread firm nontender nodules
A patient with widespread firm nontender nodules Open
A 63-year-old man with a history of chronic myelomonocytic leukemia (CMML) presented with a 2 month history of widespread nonpainful skin lesions. Otherwise he felt well and reported no systemic symptoms. On examination, there were nontend…
View article: Low Incidence of COVID-19 Infection in Patients with Acute Myeloid Leukemia Undergoing Reduced Intensity/Venetoclax Based Treatment: Initial Results of the PACE Prospective Clinical Study from the UK Trials Acceleration Program
Low Incidence of COVID-19 Infection in Patients with Acute Myeloid Leukemia Undergoing Reduced Intensity/Venetoclax Based Treatment: Initial Results of the PACE Prospective Clinical Study from the UK Trials Acceleration Program Open
The impact of Coronavirus disease 2019 (COVID-19) on outcomes in patients with cancer remains unclear. Acute Myeloid Leukemia (AML)/high-risk myelodysplasia (MDS) are common hematological malignancies resulting in profound immunosuppressio…
View article: Romboutsia‐induced bone marrow necrosis at presentation of acute myeloid leukaemia
Romboutsia‐induced bone marrow necrosis at presentation of acute myeloid leukaemia Open
Romboutsia-induced bone marrow necrosis at presentation of acute myeloid leukaemiaA 68-year-old man presented with neutropenic sepsis requiring Intensive Care Unit admission for severe community-acquired pneumonia and multi-organ failure.L…
View article: The Role of Positron Emission Tomography Imaging in the Risk-Adapted Treatment of Stage I-II Hodgkin's Lymphoma - A Retrospective Analysis
The Role of Positron Emission Tomography Imaging in the Risk-Adapted Treatment of Stage I-II Hodgkin's Lymphoma - A Retrospective Analysis Open
Materials and MethodsHospital records were used (pharmacy records, the regional cancer database, histology records and clinical notes) to identify early stage HL patients treated at our centre from 2005-2012.In 2005 a FDG PET scanner was i…
View article: Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia
Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia Open
We read with great interest the recent correspondence from Manda et al (2015) which reported a case where ibrutinib, the first-in-class Bruton tyrosine kinase inhibitor, was used successfully to treat steroid-refractory autoimmune haemolyt…